相似文献
1
Mitochondria and cell bioenergetics: increasingly recognized components and a possible etiologic cause of Alzheimer's disease.
Antioxid Redox Signal. 2012 Jun 15;16(12):1434-55. doi: 10.1089/ars.2011.4149. Epub 2011 Sep 15.
2
Mitochondria, Cybrids, Aging, and Alzheimer's Disease.
Prog Mol Biol Transl Sci. 2017;146:259-302. doi: 10.1016/bs.pmbts.2016.12.017. Epub 2017 Feb 1.
3
The Alzheimer's disease mitochondrial cascade hypothesis.
J Alzheimers Dis. 2010;20 Suppl 2(Suppl 2):S265-79. doi: 10.3233/JAD-2010-100339.
4
Mitochondria and Mitochondrial Cascades in Alzheimer's Disease.
J Alzheimers Dis. 2018;62(3):1403-1416. doi: 10.3233/JAD-170585.
5
Mitochondria, mitochondrial DNA and Alzheimer's disease. What comes first?
Curr Alzheimer Res. 2008 Oct;5(5):457-68. doi: 10.2174/156720508785908946.
6
Clinical features and pathogenesis of Alzheimer's disease: involvement of mitochondria and mitochondrial DNA.
Adv Exp Med Biol. 2010;685:34-44. doi: 10.1007/978-1-4419-6448-9_4.
7
The Alzheimer's disease mitochondrial cascade hypothesis: an update.
Exp Neurol. 2009 Aug;218(2):308-15. doi: 10.1016/j.expneurol.2009.01.011. Epub 2009 Jan 29.
8
Mitochondrial dysfunction in Alzheimer's disease: Role in pathogenesis and novel therapeutic opportunities.
Br J Pharmacol. 2019 Sep;176(18):3489-3507. doi: 10.1111/bph.14585. Epub 2019 Mar 6.
9
Inhibition of ERK-DLP1 signaling and mitochondrial division alleviates mitochondrial dysfunction in Alzheimer's disease cybrid cell.
Biochim Biophys Acta. 2014 Feb;1842(2):220-31. doi: 10.1016/j.bbadis.2013.11.009. Epub 2013 Nov 16.
10
Abnormal mitochondrial morphology in sporadic Parkinson's and Alzheimer's disease cybrid cell lines.
Exp Neurol. 2000 Mar;162(1):37-50. doi: 10.1006/exnr.2000.7333.
引用本文的文献
1
Ubiquitin-Proteasome System Dysregulation in Alzheimer's Disease Impacts Protein Abundance.
bioRxiv. 2025 May 29:2025.05.29.656728. doi: 10.1101/2025.05.29.656728.
2
Mitochondrial-based therapies for neurodegenerative diseases: a review of the current literature.
Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar 31. doi: 10.1007/s00210-025-04014-0.
3
VDAC1: A Key Player in the Mitochondrial Landscape of Neurodegeneration.
Biomolecules. 2024 Dec 30;15(1):33. doi: 10.3390/biom15010033.
4
Viruses and neurodegeneration: a growing concern.
J Transl Med. 2025 Jan 12;23(1):46. doi: 10.1186/s12967-024-06025-6.
5
Inhibiting mtDNA transcript translation alters Alzheimer's disease-associated biology.
Alzheimers Dement. 2024 Dec;20(12):8429-8443. doi: 10.1002/alz.14275. Epub 2024 Oct 23.
6
Synaptic mitochondria glycation contributes to mitochondrial stress and cognitive dysfunction.
Brain. 2025 Jan 7;148(1):262-275. doi: 10.1093/brain/awae229.
7
Neurotoxic β-amyloid oligomers cause mitochondrial dysfunction-the trigger for PANoptosis in neurons.
Front Aging Neurosci. 2024 May 14;16:1400544. doi: 10.3389/fnagi.2024.1400544. eCollection 2024.
8
TOMM40 '523 Genotype Distinguishes Patterns of Cognitive Improvement for Executive Function in APOEɛ3 Homozygotes.
J Alzheimers Dis. 2023;95(4):1697-1707. doi: 10.3233/JAD-230066.
9
Peripheral Mitochondrial Dysfunction: A Potential Contributor to the Development of Metabolic Disorders and Alzheimer's Disease.
Biology (Basel). 2023 Jul 19;12(7):1019. doi: 10.3390/biology12071019.
10
Neuroprotective effects of coenzyme Q10 on neurological diseases: a review article.
Front Neurosci. 2023 Jun 23;17:1188839. doi: 10.3389/fnins.2023.1188839. eCollection 2023.
本文引用的文献
1
Reduced mitochondria cytochrome oxidase activity in adult children of mothers with Alzheimer's disease.
J Alzheimers Dis. 2011;27(3):483-90. doi: 10.3233/JAD-2011-110866.
2
The impact of mitochondrial and nuclear DNA variants on late-onset Alzheimer's disease risk.
J Alzheimers Dis. 2011;27(1):197-210. doi: 10.3233/JAD-2011-110710.
3
Amyloid-β-induced mitochondrial dysfunction impairs the autophagic lysosomal pathway in a tubulin dependent pathway.
J Alzheimers Dis. 2011;26(3):565-81. doi: 10.3233/JAD-2011-110423.
4
Deficient brain insulin signalling pathway in Alzheimer's disease and diabetes.
J Pathol. 2011 Sep;225(1):54-62. doi: 10.1002/path.2912. Epub 2011 May 19.
5
Mild cognitive impairment, dementia, and their subtypes in oldest old women.
Arch Neurol. 2011 May;68(5):631-6. doi: 10.1001/archneurol.2011.82.
6
The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Alzheimers Dement. 2011 May;7(3):263-9. doi: 10.1016/j.jalz.2011.03.005. Epub 2011 Apr 21.
7
The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Alzheimers Dement. 2011 May;7(3):270-9. doi: 10.1016/j.jalz.2011.03.008. Epub 2011 Apr 21.
8
Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Alzheimers Dement. 2011 May;7(3):280-92. doi: 10.1016/j.jalz.2011.03.003. Epub 2011 Apr 21.
9
Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer's disease: implications for neuronal damage.
Hum Mol Genet. 2011 Jul 1;20(13):2495-509. doi: 10.1093/hmg/ddr139. Epub 2011 Mar 31.
10
Cognitive impairment and increased Aβ levels induced by paraquat exposure are attenuated by enhanced removal of mitochondrial H(2)O(2).
Neurobiol Aging. 2012 Feb;33(2):432.e15-26. doi: 10.1016/j.neurobiolaging.2011.01.008. Epub 2011 Mar 22.
Zotero 插件